Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.
Neuhauser, Magdalena
Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study. [electronic resource] - Acta oncologica (Stockholm, Sweden) Jul 2019 - 967-976 p. digital
Publication Type: Journal Article
1651-226X
10.1080/0284186X.2019.1599137 doi
Adolescent
Adult
Aged
Antineoplastic Agents, Immunological--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Austria--epidemiology
Brain Neoplasms--drug therapy
Female
Follow-Up Studies
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Methotrexate--therapeutic use
Middle Aged
Prognosis
Progression-Free Survival
Registries--statistics & numerical data
Rituximab--therapeutic use
Survival Analysis
Young Adult
Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study. [electronic resource] - Acta oncologica (Stockholm, Sweden) Jul 2019 - 967-976 p. digital
Publication Type: Journal Article
1651-226X
10.1080/0284186X.2019.1599137 doi
Adolescent
Adult
Aged
Antineoplastic Agents, Immunological--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Austria--epidemiology
Brain Neoplasms--drug therapy
Female
Follow-Up Studies
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Methotrexate--therapeutic use
Middle Aged
Prognosis
Progression-Free Survival
Registries--statistics & numerical data
Rituximab--therapeutic use
Survival Analysis
Young Adult